Skip to main content

Advertisement

Log in

Release modeling and comparison of nanoarchaeosomal, nanoliposomal and pegylated nanoliposomal carriers for paclitaxel

  • Research Article
  • Published:
Tumor Biology

Abstract

Breast cancer is the most prevalent cancer among women. Recently, delivering by nanocarriers has resulted in a remarkable evolution in treatment of numerous cancers. Lipid nanocarriers are important ones while liposomes and archaeosomes are common lipid nanocarriers. In this work, paclitaxel was used and characterized in nanoliposomal and nanoarchaeosomal form to improve efficiency. To increase stability, efficiency and solubility, polyethylene glycol 2000 (PEG 2000) was added to some samples. MTT assay confirmed effectiveness of nanocarriers on MCF-7 cell line and size measuring validated nano-scale of particles. Nanoarchaeosomal carriers demonstrated highest encapsulation efficiency and lowest release rate. On the other hand, pegylated nanoliposomal carrier showed higher loading efficiency and less release compared with nanoliposomal carrier which verifies effect of PEG on improvement of stability and efficiency. Additionally, release pattern was modeled using artificial neural network (ANN) and genetic algorithm (GA). Using ANN modeling for release prediction, resulted in R values of 0.976, 0.989 and 0.999 for nanoliposomal, pegylated nanoliposomal and nanoarchaeosomal paclitaxel and GA modeling led to values of 0.954, 0.951 and 0.976, respectively. ANN modeling was more successful in predicting release compared with the GA strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Guo J, Bourre L, Soden DM, O'Sullivan GC, O'Driscoll C. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Biotechnol Adv. 2011;29:402–17.

    Article  CAS  PubMed  Google Scholar 

  2. Blagosklonny MV. A node between proliferation, apoptosis, and growth arrest. Bioessays. 1999;21:704–9.

    Article  CAS  PubMed  Google Scholar 

  3. Rostas JW, Dyess DL. Current operative management of breast cancer: an age of smaller resections and bigger cures. Int J Breast Cancer. 2012;2012:516417.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–7.

    Article  CAS  PubMed  Google Scholar 

  5. Brasnjevic I, Steinbusch HW, Schmitz C, Martinez-Martinez P. European NanoBioPharmaceutics Research Initiative. Delivery of peptide and protein drugs over the blood–brain barrier. Prog Neurobiol. 2009;87:212–51.

    Article  CAS  PubMed  Google Scholar 

  6. Dorr RT. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother. 1994;28:11–4.

    Google Scholar 

  7. Sprott G. Structures of archaebacterial membrane lipids. J Bioenerg Biomembr. 1992;24:555–66.

    Article  CAS  PubMed  Google Scholar 

  8. Dayhoff JE. Neural network principles. 1st ed. Prentice Hall: USA; 1990.

    Google Scholar 

  9. Neocleous C, Schizas C. Artificial neural network learning: a comparative review. 1st ed. Berlin: Springer; 2002.

    Google Scholar 

  10. Richard BD, Liu YA. Neural network in bioprocessing and chemical engineering. 1st ed. USA: Academic Press; 1996.

    Google Scholar 

  11. Terfloth L, Gasteiger J. Neural networks and genetic algorithms in drug design. Genomics Suppl. 2012;6:102–8.

    Google Scholar 

  12. Mukhopadhyay DM, Balitanas MO, Farkhod AA, Jeon SH, Bhattacharyya D. Genetic algorithm: a tutorial review. Int J Grid Distrib Comput. 2009;2:25–32.

    Google Scholar 

  13. Graupe D. Principles of ANN. 2nd ed. Singapore: World Scientific Publishing; 2007.

    Google Scholar 

  14. Krishnamachari Y, Geary SM, Lemke CD, Salem AK. Nanoparticle delivery systems in cancer vaccines. Pharm Res. 2011;28:215–36.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Haykin S. Neural networks: a comprehensive foundation. 2nd ed. Prentice Hall: USA; 1998.

    Google Scholar 

  16. Laugier S, Richon D. Use of artificial neural networks for calculating derived thermodynamic quantities from volumetric property data. Fluid Phase Equilib. 2003;2:247–55.

    Article  Google Scholar 

  17. Rizkalla N, Hildgen P. Artificial neural networks: Comparison of two programs for modeling a process of nanoparticle preparation. Drug Dev Ind Pharm. 2005;31:1019–33.

    Article  CAS  PubMed  Google Scholar 

  18. Yang T, Cui FD, Choi MK, Cho JW, Chung SJ, Shim CK, et al. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm. 2007;338:317–26.

    Article  CAS  PubMed  Google Scholar 

  19. Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, et al. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm. 2005;59:177–87.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Seyed Ebrahim Alavi or Maedeh Koohi Moftakhari Esfahani.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Movahedi, F., Ebrahimi Shahmabadi, H., Alavi, S.E. et al. Release modeling and comparison of nanoarchaeosomal, nanoliposomal and pegylated nanoliposomal carriers for paclitaxel. Tumor Biol. 35, 8665–8672 (2014). https://doi.org/10.1007/s13277-014-2125-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2125-4

Keywords

Navigation